Results 141 to 150 of about 35,674 (297)

Use of Medications for Opioid Use Disorder and Child Welfare Outcomes

open access: yesJAMA Health Forum
This cohort study investigates whether use of medications for opioid use disorder in pregnancy is associated with higher rates of infants discharge home with their mothers after birth.
Muhar, Alexandra   +6 more
openaire   +2 more sources

Impact of Institutional Protocol on Urinary Catheter Outcome Measures in Orthopedic Children Treated With Epidural Analgesia

open access: yesPediatric Anesthesia, EarlyView.
ABSTRACT Background Epidural analgesia is commonly used for pain control after major lower‐limb orthopedic surgery in children, but it is associated with a risk of postoperative urinary retention. Consequently, urinary catheters are often placed and left in situ for the full duration of epidural analgesia, despite the potential risks of prolonged ...
Idan Katz   +6 more
wiley   +1 more source

Nurse Practitioners and Opioid Use Disorder

open access: yes
Since the 1990s, the opioid epidemic has seen increase in the number of opioid-related deaths. Currently, the only approved treatment for opioid use disorder (OUD) is Medication Assisted Treatment (MAT). The need for providers to be more comfortable with
Louisa Tali, and Juanita Takeno
core  

Patterns in integrative medicine usage among pediatric patients in a disorders of gut–brain interaction clinic

open access: yes
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Austin VonAxelson   +9 more
wiley   +1 more source

Codeine and Metabolite Concentrations in the Breastfed Neonate

open access: yesPediatric Anesthesia, EarlyView.
ABSTRACT Analgesic effect from codeine is from its metabolite, morphine. Morphine is formed by the O‐demethylation of codeine and that enzyme is controlled by the cytochrome P450 2D6. More than 60 alleles in the CYP2D6 gene have been identified. This spectrum of polymorphism can be categorized into four groups: poor (PM), intermediate (IM), normal (NM),
Brian J. Anderson, Jacqueline A. Hannam
wiley   +1 more source

sj-docx-1-phr-10.1177_00333549231222479 – Supplemental material for The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder

open access: yes
Supplemental material, sj-docx-1-phr-10.1177_00333549231222479 for The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder by Jill A. Dever, Marci F. Hertz, Laura
Laura J. Dunlap (17848159)   +12 more
core   +1 more source

Simulating the effects of medicaid expansion on the opioid epidemic in North Carolina

open access: yesDrug and Alcohol Dependence Reports
Expanding Medicaid plays a large role in ensuring that people across the United States have access to health care services. Although North Carolina recently moved toward Medicaid expansion, the impact of expansion on overdoses and overdose mortality may ...
Anthony Berghammer   +3 more
doaj   +1 more source

Physician’s Attitudes Toward Patients With Opioid Use Disorder and Use of Medications for Opioid Use Disorder Vary by Training

open access: yesSubstance Use & Addiction Journal
Objectives: This study compared whether different addiction treatment educational experiences were associated with physicians’ attitudes toward patients with opioid use disorder (OUD) and perceived efficacy of medications for opioid use disorder (MOUD ...
Bridget C. Bailey   +4 more
openaire   +2 more sources

Plasma Lidocaine Concentrations During Intravenous Lidocaine Infusion Therapy in the Pediatric Population—A Scoping Review

open access: yesPediatric Anesthesia, EarlyView.
ABSTRACT Background Intravenous lidocaine therapy (IVLT) is often used in perioperative multimodal analgesia due to its analgesic, anti‐hyperalgesic, and anti‐inflammatory effects. In adults, IVLT doses of 1–2 mg/kg/h produce plasma concentrations of 1–2 μg/mL, within the presumed therapeutic range of 1–5 μg/mL.
McKenna Postles   +3 more
wiley   +1 more source

Median Effective Volume of 0.2% Ropivacaine for Ultrasound‐Guided Axillary Brachial Plexus Block in Children Aged 6–10 Years: A Prospective Dose‐Finding Study Using Up‐and‐Down Sequential Allocation

open access: yesPediatric Discovery, EarlyView.
Purpose: This study aimed to determine the median effective volume (EV50) of 0.2% ropivacaine for ultrasound‐guided axillary brachial plexus block (ABPB) in children aged 6–10 years, using the Dixon up‐and‐down method. The EV50 was 0.350 mL/kg (95% CI: 0.197–0.362 mL/kg), calculated by isotonic regression and bootstrapping.
Tauseef Ahmad   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy